Application Notes

This application note outlines a solid-phase extraction (SPE) and LC–MS/MS method for the analysis of 19 synthetic cannabinoids in urine.

In this technical note we show peptides and proteins identification using the bioZen nano XB-C18 column in either direct inject or trap and elute mode.

Sub-2 μm fully porous particles and core-shell particles in nano LC–MS were evaluated by separation performance and protein and peptide identifications in proteomics.

The effect of column selectivity, its importance in quality of data achieved in protein and peptide identifications in bottom-up proteomics applications, is demonstrated.

bioZen Nano 75 µm LC columns offer two advanced particle platforms, three unique column chemistries, and SecurityLINK Fitting Technology for a zero-dead volume connection.

In this application note we explore the effects of trap loadability using a bioZen 3 μm Polar C18 nano column in conjunction with the bioZen RP1 (C18) nano trap column.

In this technical note we provide a miniaturized LC–MS and SPE method for the reliable and accurate detection of viral pesticides.

Multiple selectivity options in nano LC columns allows users to tailor the chromatography for the compounds of interest to the researcher.

We demonstrate how to achieve deep proteome coverage on HeLa cell lysate using a high pH reversed-phase fractionation strategy in combination with nano flow LC–MS.

The bioZen high pH fractionation HPLC column provides superior performance using titanium hardware, minimizing nonspecific adsorption for peptide identifications.

In this technical note we explore column miniaturization effects attained by reducing column ID from 300 μm to 75 μm and its effects on sensitivity.

In this application we show reproducible results across multiple columns as well as the robust ability of the bioZen 2.6 μm XB-C18 column after 100 injections.

Charge variants of 28 mAbs were analyzed under MS-compatible conditions using YMC’s BioPro IEX SF column. Each mAb of different pI was separated from its variants

Charge variants of 28 mAbs were analyzed under MS-compatible conditions using YMC’s BioPro IEX SF column. Each mAb of different pI was separated from its variants

In reference to the Japanese Pharmacopeia, YMC-Triart Bio C18 was used to analyze the peptide leuprorelin (GnRH analogue) and separate it from its degradation products.

In this application note, YMC’s dedicated SEC column for antibodies, YMC-SEC MAB, has been used to develop a method for bevacizumab using MALLS detection.

Charge variants of 28 mAbs were analyzed under MS-compatible conditions using YMC’s BioPro IEX SF column. Each mAb of different pI was separated from its variants

Mipomersen was analyzed by LC–HRMS using a biocompatible YMC-Triart C8 metal-free column ensuring symmetric peaks, high sensitivity, and no carryover effects.

The antibody-drug conjugate was separated from its aggregates and fragments in only one run using a YMC-SEC MAB column and varying mobile phases.

In this application note, the DAR of the SigmaMAb ADC-mimic was determined using YMC’s BioPro HIC BF column and a nanospray ionization mass spectrometer.

IONICON real-time VOC analyzers are frequently deployed in mobile laboratories, contributing to public safety, tracking air pollution where and when it matters.

The unique design of the 50 cm μPAC™ GEN2 nanoLC column provides superior performance over state-of-the-art packed bed columns, achieving peak capacities of over 1000.